Skip to main content

Ongoing FDAEvent 99698 (1 month ago)

Bayer Medical Care MEDRAD Stellant FLEX Syringe Kit

The syringe kit may not be properly sterilized due to a manufacturing issue.

Moderate risk

Using it may cause temporary or medically reversible health problems. Serious harm is unlikely.

FDA Class II recall · How risk is rated

What to do

What happened

Bayer Medical Care, Inc., of Indianola, Pennsylvania, recalled the MEDRAD Stellant FLEX Syringe Kit used with the Stellant FLEX CT Injection System because some devices may not have been properly sterilized due to a manufacturing sterilization issue. The recall, which began July 31, 2026, involves 27,800 kits (556 boxes) and was added to the FDA's Enforcement Report on September 11, 2026. The kits were distributed nationwide in the US.

Summary by Recall Canary from the FDA notice.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is your kit affected?

Match the UDI-DI, lot code and catalog code listed under your product.

  1. MEDRAD¿ Stellant FLEX Syringe Kit used with Stellant FLEX ct Injection System

    UDI-DI
    • 00616258022895
    • 87078825
    Catalog code
    • FLEXS-150-QFT
    Lot
    • 8688750

Details

Company began the recall
Sold in

US Nationwide distribution.

Event ID
99698
Recall No.
Z-3147-2026
Company
Bayer Medical Care, Inc.Indianola, Pennsylvania
Quantity recalled
27800 kits (556 boxes)
Recall type
Voluntary: Firm initiated
Customers told by
Telephone
  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. Listed on Recall Canary

  4. In FDA's weekly enforcement report

  5. Summary updated

All recalls from Bayer Medical Care, Inc.

Summary by Recall Canary, written with AI · summary updated Oct 2, 2026 · primary source: U.S. Food and Drug Administration